Whole-body biodistribution and radiation dosimetry of the new cardiac tracer99mTc-N-DBODC

Journal of Nuclear Medicine

Volumn 49, Issue 8, 2008, Pages 1299-1304

  Cittanti, Corrado ^a   Uccelli, Licia ^a   Pasquali, Micol ^a   Boschi, Alessandra ^a   Flammia, Claudia ^a   Bagatin, Elisa ^a   Casali, Massimiliano ^a   Stabin, Michael G ^b   Feggi, Luciano ^c   Giganti, Melchiore ^a   Duatti, Adriano ^a  

^a UNIVERSITY OF FERRARA   (Italy)

^b VANDERBILT UNIVERSITY   (United States)

^c UNIVERSITY HOSPITAL OF FERRARA   (Italy)

Author keywords

99mTC; Cardiac perfusion imaging; Monocationic complexes; Nitrido complexes

Indexed keywords

BIS[(DIMETHOXYPROPYLPHOSPHANYL)ETHYL]ETHOXYETHYLAMINE N,N' BIS(ETHOXYETHYL)DITHIOCARBAMATO NITRIDO TC 99M; TRACER; UNCLASSIFIED DRUG;

ADULT; ARTICLE; BLOOD; BODY FLUID; CONTROLLED STUDY; DOSIMETRY; DRUG ACCUMULATION; DRUG CLEARANCE; DRUG DISTRIBUTION; DRUG RETENTION; EXERCISE; HEART; HEART MUSCLE; HUMAN; HUMAN EXPERIMENT; LIVER; LUNG; MALE; NORMAL HUMAN; PRIORITY JOURNAL; RADIOACTIVITY; REST; SCINTILLATION CAMERA; STRESS; URINE;

ADULT; HEART; HUMANS; MALE; MIDDLE AGED; ORGAN SPECIFICITY; ORGANOPHOSPHORUS COMPOUNDS; ORGANOTECHNETIUM COMPOUNDS; RADIATION DOSAGE; RADIOPHARMACEUTICALS; WHOLE BODY IMAGING;

EID: 48749106207     PISSN: 01615505     EISSN: None     Source Type: Journal    
DOI: 10.2967/jnumed.108.053132     Document Type: Article

References (19)

1. 99Tc, Re; DTC = dithiocarbamate; PNP = heterodiphosphane). Eur J Inorg Chem. 2004;9:1902-1913.
2. 99mTc-nitride heterocomplexes showing high heart uptake and improved imaging properties. J Nucl Med. 2003;44:806-814.
3. 99mTc heterocomplexes as heart imaging agents with improved biological properties. Nucl Med Commun. 2002;23:689-693.
4. 99mTc-tetrofosmin in rats. J Nucl Med. 2004;45:2095-2101.
5. Hatada K, Ruiz M, Riou LM, et al. Biodistribution and myocardial uptake, washout, and redistribution kinetics of Tc-99m N-DBODC5 when injected during vasodilator stress in canine models of coronary stenoses. J Nucl Cardiol. 2006;13:779-790.
6. Stabin MG, Sparks RB, Crowe E. OLINDA/EXM: the second-generation personal computer software for internal dose assessment in nuclear medicine. J Nucl Med. 2005;46:1023-1027.
7. Foster DM. Developing and testing integrated multicompartment models to describe a single-input multiple-output study using the SAAM II software system. In: Clifford AJ, Müller H-G, eds. Mathematical Modeling in Experimental Nutrition. New York, NY: Plenum Press; 1998:59-78.
8. Wackers FJ, Berman DS, Maddahi J, et al. Technetium-99m hexakis 2-methoxy-isobutyl isonitrile: human biodistribution, dosimetry, safety, and preliminary comparison to thallium-201 for myocardial perfusion imaging. J Nucl Med. 1989;30:301-311.
9. Higley B, Smith FW, Smith T, et al. Technetium-99m-1,2-bis[bis(2- ethoxyethyl)phosphino]ethane: human biodistribution, dosimetry and safety of a new myocardial perfusion imaging agent. J Nucl Med. 1993;34:30-38.
10. Rohe RC, Thomas SR, Stabin MG, et al. Biokinetics and dosimetry analysis in healthy volunteers for a two-injection (rest-stress) protocol of the myocardial perfusion imaging agent technetium 99m-labeled Q3. J Nucl Cardiol. 1995;2:395-404.
11. 99mTcNNOET in healthy volunteers. J Nucl Med. 2000;41:141-148.
12. ICRP. ICRP Publication 18: Radiation Dose to Patients from Radiopharmaceuticals. Oxford, U.K.: Pergamon Press; 1987:1-29.
13. Beller GA, Bergmann SR. Myocardial perfusion imaging agents: SPECT and PET. J Nucl Cardiol. 2004;11:71-86.
14. Jain D. Technetium-99m myocardial perfusion imaging agents. Semin Nucl Med. 1999;29:221-236.
15. 201Tl and myocardial blood flow. Circulation. 1997;96:2325-2331.
16. Fagret D, Marie PY, Brunotte F, et al. Myocardial perfusion imaging with technetium-99m-Tc-NOET: comparison with thallium-201 and coronary angiography. J Nucl Med. 1995;36:936-943.
17. Jeetley P, Sabharwal NK, Soman P, et al. Comparison between Tc-99m N-NOET and Tl-201 in the assessment of patients with known or suspected coronary artery disease. J Nucl Cardiol. 2004;11:664-672.
18. Stern S, Greenberg D, Corne R. Quantification of walking exercise required for improvement of dipyridamole thallium-201 image quality. J Nucl Med. 1992;33:2061-2066.
19. Vitola JV, Brambatti JC, Caligaris F, et al. Exercise supplementation to dipyridamole prevents hypotension, improves electrocardiogram sensitivity, and increases heart-to-liver activity ratio on Tc-99m sestamibi imaging. J Nucl Cardiol. 2001;8:652-659.